These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 12845862

  • 1. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
    Sudhop T, von Bergmann K.
    MMW Fortschr Med; 2003 May 22; 145(21):19. PubMed ID: 12845862
    [No Abstract] [Full Text] [Related]

  • 2. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun 15; 148(24):6. PubMed ID: 16850797
    [No Abstract] [Full Text] [Related]

  • 3. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
    MMW Fortschr Med; 2005 Nov 10; 147(45):54. PubMed ID: 16320655
    [No Abstract] [Full Text] [Related]

  • 4. [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].
    MMW Fortschr Med; 2005 Nov 10; 147(45):55. PubMed ID: 16320656
    [No Abstract] [Full Text] [Related]

  • 5. [Substantiation of increasing doses of statins in clinical practice].
    Susekov AV.
    Ter Arkh; 2001 Nov 10; 73(4):76-80. PubMed ID: 11494456
    [No Abstract] [Full Text] [Related]

  • 6. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M.
    MMW Fortschr Med; 2003 Feb 27; 145(9):35-6. PubMed ID: 12666527
    [No Abstract] [Full Text] [Related]

  • 7. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
    Robinson JG, Davidson MH.
    Expert Rev Cardiovasc Ther; 2006 Jul 27; 4(4):461-76. PubMed ID: 16918265
    [Abstract] [Full Text] [Related]

  • 8. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug 18; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract] [Full Text] [Related]

  • 9. [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl].
    MMW Fortschr Med; 2004 Oct 28; 146(44):57. PubMed ID: 15566254
    [No Abstract] [Full Text] [Related]

  • 10. [60% of patients with coronary disease receive antilipemic drugs. Nevertheless cholesterol often is too high].
    MMW Fortschr Med; 2001 Nov 01; 143(44):60. PubMed ID: 11732408
    [No Abstract] [Full Text] [Related]

  • 11. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug 18; 147(33-34):51. PubMed ID: 16138641
    [No Abstract] [Full Text] [Related]

  • 12. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW.
    Curr Med Res Opin; 2008 Mar 18; 24(3):685-94. PubMed ID: 18226326
    [Abstract] [Full Text] [Related]

  • 13. [Ezetimib plus statin combination. A strong duo].
    MMW Fortschr Med; 2002 Nov 28; 144(48):53. PubMed ID: 12532547
    [No Abstract] [Full Text] [Related]

  • 14. C-reactive protein levels and outcomes after statin therapy.
    Clearfield M.
    Curr Atheroscler Rep; 2006 Jan 28; 8(1):8-9. PubMed ID: 16455006
    [No Abstract] [Full Text] [Related]

  • 15. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D.
    Rep Med Guidel Outcomes Res; 2004 Aug 06; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract] [Full Text] [Related]

  • 16. [High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].
    Einecke D.
    MMW Fortschr Med; 2006 Jun 15; 148(24):4-5. PubMed ID: 16850796
    [No Abstract] [Full Text] [Related]

  • 17. C-reactive protein levels and outcomes after statin therapy.
    Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E, Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators.
    N Engl J Med; 2005 Jan 06; 352(1):20-8. PubMed ID: 15635109
    [Abstract] [Full Text] [Related]

  • 18. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 06; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 19. [Lowering of cholesterol. What role is played by the choice of statins?].
    März W.
    MMW Fortschr Med; 2004 Sep 02; 146(35-36):55. PubMed ID: 15540544
    [No Abstract] [Full Text] [Related]

  • 20. [First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].
    Einecke D.
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):38. PubMed ID: 14974329
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.